Brain, Vol. 122, No. 9, 1629-1635,
September 1999
© 1999 Oxford University Press
Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache
1 Department of Neurology, Glostrup Hospital, University of Copenhagen, Denmark and 2 Department of Medicine, Kitasato University, Sagamihara, Japan
Correspondence to:
Messoud Ashina, Department of Neurology, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Copenhagen, Denmark E-mail: ashina{at}dadlnet.dk
It has been demonstrated recently that nitric oxide synthase (NOS) inhibition has an analgesic effect in patients with chronic tension-type headache. The aim of the present study was to investigate the influence of the NOS inhibitor, L-NG methyl arginine hydrochloride (L-NMMA), on two of the most prominent features of chronic tension-type headache, i.e. increased muscle hardness and increased myofascial tenderness. In a double blind, crossover designed trial, 16 patients with chronic tension-type headache were randomized to receive intravenous infusion of 6 mg/kg L-NMMA or placebo on 2 days separated by at least 1 week. Muscle hardness of the trapezius muscle was measured with a hardness meter. Myofascial tenderness in the pericranial region was evaluated by manual palpation with standardized and validated methodology. All parameters were recorded at baseline and at 60 and 120 min after start of infusion. Compared with baseline, muscle hardness, 107 ± 17 kPa/cm and tenderness, 18 ± 11 were significantly reduced at 60 and 120 min to: hardness, 101 ± 17 kPa/cm and 101 ± 17 kPa/cm, respectively; tenderness, 15 ± 11 and 14 ± 11, respectively, after treatment with L-NMMA (P < 0.05 and P < 0.01, respectively), while there was no significant reduction at any time after treatment with the placebo. Compared with the placebo, the summary score of muscle hardness was significantly reduced (P = 0.04), while tenderness showed a non-significant reduction (P = 0.11) following treatment with L-NMMA. Since increased muscle hardness in patients with chronic tension-type headache may reflect sensitization of second order neurons due to prolonged nociceptive input from myofascial tissues, we suggest that the decrease in muscle hardness following treatment with L-NMMA may be caused by reduction of central sensitization.
tension-type headache; nitric oxide; central sensitization; myofascial tenderness, muscle hardness
L-NMMA = L-NGmethyl arginine hydrochloride; NO = nitric oxide; NOS = nitric oxide synthase; PPDT = pressure pain detection thresholds; TTS = total tenderness score; VAS = visual analogue scale
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Koulchitsky, M. J.M. Fischer, R. De Col, P. M. Schlechtweg, and K. Messlinger Biphasic Response to Nitric Oxide of Spinal Trigeminal Neurons With Meningeal Input in Rat-Possible Implications for the Pathophysiology of Headaches J Neurophysiol, September 1, 2004; 92(3): 1320 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S O. Narin, L Pinar, D Erbas, V Ozturk, and F Idiman The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache Clinical Rehabilitation, June 1, 2003; 17(6): 624 - 630. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Ashina, B. Stallknecht, L. Bendtsen, J. F. Pedersen, H. Galbo, P. Dalgaard, and J. Olesen In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache Brain, February 1, 2002; 125(2): 320 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goadsby Chronic tension-type headache: where are we? Brain, September 1, 1999; 122(9): 1611 - 1612. [Full Text] [PDF]
|
|